Epidemiology, Screening, and Prevention of Bladder Cancer
Niyati Lobo(The University of Texas MD Anderson Cancer Center), Yair Lotan(Southwestern Medical Center), Luca Afferi(Universitat Autònoma de Barcelona), Sima P. Porten(City College of San Francisco), Stephen B. Williams(Cedars-Sinai Medical Center), Hugh Mostafid, Marco Moschini(Vita-Salute San Raffaele University), Angela B. Smith(Communities In Schools of Orange County), Sarah P. Psutka(University of Washington Medical Center), Shilpa Gupta(Cleveland Clinic)
Cited by 361
Related Papers
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
|Journal of the American College of Cardiology|1996|1k
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
|Journal of Clinical Oncology|2016|859
Acute Hyperglycemia Attenuates Endothelium-Dependent Vasodilation in Humans In Vivo
|Circulation|1998|804
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688